DXSP DXS International PLC

Notice of AGM

Notice of AGM

DXS INTERNATIONAL PLC

Notice of 2023 Annual General Meeting

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, confirms that its Annual General Meeting is scheduled to take place on Thursday 30th November 2023 at Noon at the Pavilion Café, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.

For further information in relation to the AGM, shareholders should refer to the Notice of Annual General Meeting and the AGM Letter which have been despatched to shareholders. Copies of these documents, along with the Company's Annual Report for the year ended 30 April 2023, are available for download from the Company's website .

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman      (Chief Executive)

DXS International plc		01252 719800

Suite 2, Second Floor

Ash House, Tanshire Park

Shackleford Road

Elstead, Surrey

GU8 6LB



 		 
-systems.co.uk 



Corporate Advisor



 		 
David Papworth

City & Merchant		0207 101 7676



 



Corporate Broker



 		 
Hybridan LLP

Claire Louise Noyce



 		020 3764 2341



 

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.



EN
06/11/2023

Underlying

DXSPDXS International PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

 PRESS RELEASE
Free
DXSP DXS Internation...

Statement re Grant of Options and Warrants

Statement re Grant of Options and Warrants DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, announces that it yesterday granted share options to a number of directors, employees, and consultants. Most of these options grants are under an Enterprise Management Incentive (“EMI”) scheme and the remainder under an unapproved share option scheme. All these Share Options are at an exercise pric...

April 29, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 13 February, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,333.756 Ordinary Shares representing 2.0...

February 14, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 31 January, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,303.756 Ordinary Shares representing 2.04...

February 10, 2025 1 EN
Hybridan Team
  • Hybridan Team
TWOU 2U INC.
RUA Rua Life Scienc... ... (+8)

Hybridan Monthly, 3 February 2025

2025: The year of the Phoenix, NOT the Unicorn The pursuit of Unicorn companies valued at $1bn+ will always be newsworthy and exciting. VCs, Private Equity, Governments and Global Stock Exchanges will continue to fight and clamber over one another for the chance of courting them. Our collective attention should therefore not be where support is needed least. Our attention needs to be diverted back to the exciting and unloved. The majestic Phoenix company; known for its ability to be reborn f...

TWOU 2U INC.
RUA RUA LIFE SCIENCES
HAT H&T GROUP
PRES PRESSURE TECHNOLOGIES
DXSP DXS INTERNATIONAL PLC
NEXS NEXUS INFRASTRUCTURE
HDD HARDIDE PLC
CTA CT AUTOMOTIVE GROUP PLC
02/04/25 February 4, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 31 January, Mr Bob Sutcliffe, the Chairman, purchased 20,000 Ordinary Shares in the Company at a price of 3.5p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,273,756 Ordinary Shares representing 1.99%...

February 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch